-
-
-
-
-
-
-
FDA Grants Orphan Drug and Pediatric Exclusivities for CRESEMBA® (isavuconazonium sulfate) for Invasive Aspergillosis and Invasive Mucormycosis in Children
-
-
-
-
-
-
-
U.S. FDA Grants Regular Approval and Expands Indication for PADCEV® (enfortumab vedotin-ejfv) for Patients with Locally Advanced or Metastatic Urothelial Cancer
-
-
68,948 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


